Michihiko Goto1,2, Amy M J O'Shea1,2, Daniel J Livorsi1,2, Jennifer S McDanel1,2, Makoto M Jones3,4, Kelly K Richardson1, Brice F Beck1, Bruce Alexander1, Martin E Evans5,6,7, Gary A Roselle8,9,10, Stephen M Kralovic8,9,10, Eli N Perencevich1,2. 1. Iowa City Veterans Affairs (VA) Health Care System. 2. University of Iowa Carver College of Medicine, Iowa City. 3. Salt Lake City VA Health Care System. 4. University of Utah School of Medicine, Salt Lake City. 5. Veterans Health Administration (VHA) MDRO Program Office. 6. Lexington VA Medical Center. 7. University of Kentucky College of Medicine, Lexington. 8. VHA National Infectious Diseases Service. 9. Cincinnati VA Medical Center. 10. University of Cincinnati College of Medicine, Ohio.
Abstract
BACKGROUND: The Veterans Health Administration (VHA) introduced the Methicillin-Resistant Staphylococcus aureus (MRSA) Prevention Initiative in March 2007. Although the initiative has been perceived as a vertical intervention focusing on MRSA, it also expanded infection prevention and control programs and resources. We aimed to assess the horizontal effect of the initiative on hospital-onset (HO) gram-negative rod (GNR) bacteremia. METHODS: This retrospective cohort included all patients who had HO bacteremia due to Escherichia coli, Klebsiella species, or Pseudomonas aeruginosa at 130 VHA facilities from January 2003 to December 2013. The effects were assessed using segmented linear regression with autoregressive error models, incorporating autocorrelation, immediate effect, and time before and after the initiative. Community-acquired (CA) bacteremia with same species was also analyzed as nonequivalent dependent controls. RESULTS: A total of 11 196 patients experienced HO-GNR bacteremia during the study period. There was a significant change of slope in HO-GNR bacteremia incidence rates from before the initiative (+0.3%/month) to after (-0.4%/month) (P < .01), while CA GNR incidence rates did not significantly change (P = .08). Cumulative effect of the intervention on HO-GNR bacteremia incidence rates at the end of the study period was estimated to be -43.2% (95% confidence interval, -51.6% to -32.4%). Similar effects were observed in subgroup analyses of each species and antimicrobial susceptibility profile. CONCLUSIONS: Within 130 VHA facilities, there was a sustained decline in HO-GNR bacteremia incidence rates after the implementation of the MRSA Prevention Initiative. As these organisms were not specifically targeted, it is likely that horizontal components of the initiative contributed to this decline. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: The Veterans Health Administration (VHA) introduced the Methicillin-Resistant Staphylococcus aureus (MRSA) Prevention Initiative in March 2007. Although the initiative has been perceived as a vertical intervention focusing on MRSA, it also expanded infection prevention and control programs and resources. We aimed to assess the horizontal effect of the initiative on hospital-onset (HO) gram-negative rod (GNR) bacteremia. METHODS: This retrospective cohort included all patients who had HO bacteremia due to Escherichia coli, Klebsiella species, or Pseudomonas aeruginosa at 130 VHA facilities from January 2003 to December 2013. The effects were assessed using segmented linear regression with autoregressive error models, incorporating autocorrelation, immediate effect, and time before and after the initiative. Community-acquired (CA) bacteremia with same species was also analyzed as nonequivalent dependent controls. RESULTS: A total of 11 196 patients experienced HO-GNR bacteremia during the study period. There was a significant change of slope in HO-GNR bacteremia incidence rates from before the initiative (+0.3%/month) to after (-0.4%/month) (P < .01), while CA GNR incidence rates did not significantly change (P = .08). Cumulative effect of the intervention on HO-GNR bacteremia incidence rates at the end of the study period was estimated to be -43.2% (95% confidence interval, -51.6% to -32.4%). Similar effects were observed in subgroup analyses of each species and antimicrobial susceptibility profile. CONCLUSIONS: Within 130 VHA facilities, there was a sustained decline in HO-GNR bacteremia incidence rates after the implementation of the MRSA Prevention Initiative. As these organisms were not specifically targeted, it is likely that horizontal components of the initiative contributed to this decline. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Haley J Appaneal; Aisling R Caffrey; Maria-Stephanie A Hughes; Vrishali V Lopes; Robin L P Jump; Kerry L LaPlante; David M Dosa Journal: J Am Med Dir Assoc Date: 2019-08-26 Impact factor: 4.669
Authors: E Kousouli; O Zarkotou; L Politi; K Polimeri; G Vrioni; K Themeli-Digalaki; A Tsakris; S Pournaras Journal: Eur J Clin Microbiol Infect Dis Date: 2017-09-06 Impact factor: 3.267
Authors: Richard E Nelson; Vanessa W Stevens; Makoto Jones; Karim Khader; Marin L Schweizer; Eli N Perencevich; Michael A Rubin; Matthew H Samore Journal: Antimicrob Agents Chemother Date: 2018-10-24 Impact factor: 5.191
Authors: Charlesnika T Evans; Margaret Fitzpatrick; Swetha Ramanathan; Stephen M Kralovic; Stephen P Burns; Barry Goldstein; Bridget Smith; Dale N Gerding; Stuart Johnson Journal: J Spinal Cord Med Date: 2019-10-30 Impact factor: 1.985
Authors: Karina-Doris Vihta; Nicole Stoesser; Martin J Llewelyn; T Phuong Quan; Tim Davies; Nicola J Fawcett; Laura Dunn; Katie Jeffery; Chris C Butler; Gail Hayward; Monique Andersson; Marcus Morgan; Sarah Oakley; Amy Mason; Susan Hopkins; David H Wyllie; Derrick W Crook; Mark H Wilcox; Alan P Johnson; Tim E A Peto; A Sarah Walker Journal: Lancet Infect Dis Date: 2018-08-17 Impact factor: 25.071
Authors: Michihiko Goto; Jennifer S McDanel; Makoto M Jones; Daniel J Livorsi; Michael E Ohl; Brice F Beck; Kelly K Richardson; Bruce Alexander; Eli N Perencevich Journal: Emerg Infect Dis Date: 2017-11 Impact factor: 6.883
Authors: Makoto Jones; John A Jernigan; Martin E Evans; Gary A Roselle; Kelly M Hatfield; Matthew H Samore Journal: MMWR Morb Mortal Wkly Rep Date: 2019-03-08 Impact factor: 17.586
Authors: Nadim G El Chakhtoura; Elie Saade; Brigid M Wilson; Federico Perez; Krisztina M Papp-Wallace; Robert A Bonomo Journal: Clin Infect Dis Date: 2017-10-15 Impact factor: 9.079